Chaofeng Mu
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
-
- Advanced Drug Delivery Systems 6
- Hematology 10
- Acute Myeloid Leukemia Research 7
- Hematopoietic Stem Cell Transplantation 4
- Co-authors
- Haifa ShenJoy WolframJianliang ShenJunhua MaiYongmei YinFude CuiDae‐Duk KimChang‐Koo Shim
- Journals
- International Journal of Pharmaceutics (5 papers)Journal of Controlled Release (3 papers)Acta Pharmaceutica Sinica B (2 papers)Theranostics (2 papers)Advanced Healthcare Materials (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Chaofeng Mu
52 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 112
- Biomaterials 684
- Pharmaceutical Science 288
- Oncology 399
- Biomedical Engineering 602
- Molecular Biology 929
Countries citing papers authored by Chaofeng Mu
This map shows the geographic impact of Chaofeng Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaofeng Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaofeng Mu more than expected).
Fields of papers citing papers by Chaofeng Mu
This network shows the impact of papers produced by Chaofeng Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaofeng Mu. The network helps show where Chaofeng Mu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chaofeng Mu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 6 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 6 | |
| 11 | 2021 | 34 | |
| 12 | 2020 | 20 | |
| 13 | 2019 | 35 | |
| 14 | 2018 | 27 | |
| 15 | 2017 | 37 | |
| 16 | 2016 | 5 | |
| 17 | 2016 | 50 | |
| 18 | 2015 | 78 | |
| 19 | 2010 | 169 | |
| 20 | 2009 | 265 |
About Chaofeng Mu
Chaofeng Mu is a scholar working on Pharmaceutical Science, Hematology, Biomaterials, Oncology and Molecular Biology, having authored 53 papers that have together received 2.0k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (12 papers), RNA Interference and Gene Delivery (11 papers), Nanoparticle-Based Drug Delivery (11 papers), Nanoplatforms for cancer theranostics (7 papers), Acute Myeloid Leukemia Research (7 papers), Advanced Drug Delivery Systems (6 papers), Cancer Cells and Metastasis (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). The work is most often cited by research in Biomaterials (684 citations), Pharmaceutical Science (288 citations), Oncology (399 citations), Biomedical Engineering (602 citations) and Molecular Biology (929 citations). Chaofeng Mu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Haifa Shen, Joy Wolfram, Jianliang Shen, Junhua Mai, Yongmei Yin, Fude Cui, Dae‐Duk Kim, Chang‐Koo Shim, Suk‐Jae Chung and Zong‐Wan Mao. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, Acta Pharmaceutica Sinica B, Theranostics and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.